Double‐Layer Microneedle Patch Loaded with HA‐PBA‐QCT for Management of Paclitaxel‐Induced Peripheral Neuropathic Pain
Small · 2025-02 · 21 (8)
DOI: 10.1002/smll.202409748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 31.01.2025. Verfasst von Yunfan Kong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mary & Dick Holland Regenerative Medicine Program University of Nebraska Medical Center, Omaha, NE, 68198, USA. Hauptthemen laut MEDLINE: Paclitaxel, Neuralgia, Needles, Hyaluronic Acid. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: UNMC Center for Drug Design and Innovation (CDDI) Seed Grant, UNMC Graduate Studies Fellowship, Nebraska Department of Health and Human Services.
Abstract (Originalsprache)
Chemotherapy‐induced neuropathic pain (CINP) is a common adverse effect of antineoplastic drugs, often leading to dose reduction, treatment delays, or cessation of chemotherapy. Chemotherapy agents, like paclitaxel (PTX), damage the somatosensory nervous system by inducing neuroinflammation and oxidative stress, resulting in the sensitization of sensory neurons. Quercetin (QCT), known for its anti‐inflammatory, antioxidant, and neuroprotective properties, is investigated for various neurological disorders. This work creates phenylboronic acid‐modified hyaluronic acid (HA‐PBA) gels with incorporated QCT and fabricates a double‐layer microneedle (MN) patch using an HA‐PBA‐QCT complex in the needles and HA/polyvinyl alcohol (PVA) as the substrate. The crosslinking between PVA and HA‐PBA‐QCT enables a controlled, sustained release of QCT upon application. This work applies these QCT‐loaded microneedle (QMN) patches to the instep skin of PTX‐treated mice, which exhibits mechanical allodynia and cold hyperalgesia. Biweekly applications of the QMN patches significantly reduce pain responses. This analgesic effect is associated with the modulation of satellite glial cell activity, decreased macrophage infiltration, and reduced TNF‐α and IL‐6 levels in dorsal root ganglia (DRGs). Additionally, the treatment improves cellular antioxidant capacity, indicated by upregulated Nrf2 and catalase in DRGs. Overall, these findings suggest that double‐layer QMN patches offer long‐term anti‐inflammatory and antioxidant benefits, potentially alleviating CINP in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mary & Dick Holland Regenerative Medicine Program University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Division of Cardiology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Department of Surgery, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Department of Mechanical and Materials Engineering, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
ORCID-Profile: Tianshu Pan, Bin Duan
Förderung
- UNMC Center for Drug Design and Innovation (CDDI) Seed Grant
- UNMC Graduate Studies Fellowship
- Nebraska Department of Health and Human Services
- NIAMS NIH HHS
- NINDS NIH HHS
Zitieren
APA
Kong, Y., Pan, T., Liu, B., Kuss, M., Krishnan, M. A., Alimi, O. A., Shi, W., & Duan, B. (2025). Double‐Layer Microneedle Patch Loaded with HA‐PBA‐QCT for Management of Paclitaxel‐Induced Peripheral Neuropathic Pain. Small, 21(8). https://doi.org/10.1002/smll.202409748
Vancouver
Kong Y, Pan T, Liu B, Kuss M, Krishnan MA, Alimi OA, et al. Double‐Layer Microneedle Patch Loaded with HA‐PBA‐QCT for Management of Paclitaxel‐Induced Peripheral Neuropathic Pain. Small. 2025;21(8). doi:10.1002/smll.202409748
BibTeX
@article{Kong2025,
author = {Kong, Yunfan and Pan, Tianshu and Liu, Bo and Kuss, Mitchell and Krishnan, Mena A and Alimi, Olawale A and Shi, Wen and Duan, Bin},
title = {Double‐Layer Microneedle Patch Loaded with HA‐PBA‐QCT for Management of Paclitaxel‐Induced Peripheral Neuropathic Pain},
journal = {Small},
year = {2025},
volume = {21},
number = {8},
doi = {10.1002/smll.202409748}
}
EUVIMED